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Abstract
Background: The Plasmodium falciparum P126 protein is an asexual blood-stage malaria vaccine
candidate antigen. Antibodies against P126 are able to inhibit parasite growth in vitro, and a major
parasite-inhibitory epitope has been recently mapped to its 47 kDa N-terminal extremity (octamer
repeat domain – OR domain). The OR domain basically consists of six octamer units, but variation
in the sequence and number of repeat units may appear in different alleles. The aim of the present
study was to investigate the polymorphism of P126 N-terminal region OR domain in P. falciparum
isolates from two Brazilian malaria endemic areas and its impact on anti-OR naturally acquired
antibodies.
Methods: The study was carried out in two villages, Candeias do Jamari (Rondonia state) and
Peixoto de Azevedo (Mato Grosso state), both located in the south-western part of the Amazon
region. The repetitive region of the gene encoding the P126 antigen was PCR amplified and
sequenced with the di-deoxy chain termination procedure. The antibody response was evaluated
by ELISA with the Nt47 synthetic peptide corresponding to the P126 OR-II domain.
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Results: Only two types of OR fragments were identified in the studied areas, one of 175 bp (OR-
I) and other of 199 bp (OR-II). A predominance of the OR-II fragment was observed in Candeias
do Jamari whereas in Peixoto de Azevedo both fragments OR-I and OR-II were frequent as well as
mixed infection (both fragments simultaneously) reported here for the first time. Comparing the
DNA sequencing of OR-I and OR-II fragments, there was a high conservation among predicted
amino acid sequences of the P126 N-terminal extremity. Data of immune response demonstrated
that the OR domain is highly immunogenic in natural conditions of exposure and that the
polymorphism of the OR domain does not apparently influence the specific immune response.
Conclusion: These findings confirm a limited genetic polymorphism of the P126 OR domain in P.
falciparum isolates and that this limited genetic polymorphism does not seem to influence the
development of a specific humoral immune response to P126 and its immunogenicity in the studied
population.
Background
The  Plasmodium falciparum P126 protein is an asexual
blood-stage malaria vaccine candidate antigen. P126, also
referred to as SERA [1] and SERP [2], is synthesized during
the late trophozoite and schizont stages being secreted in
the lumen of the parasitophorous vacuole [3], estimated
by proteomic studies to be one of the most abundant pro-
tein expressed at the schizont stage [4]. Upon release of
merozoites from mature schizonts, P126 is processed into
fragments of 50 and 73 kD, the latter composed of two
peptides of 47 and 18 kD linked by disulfide bridges.
These fragments are released into the bloodstream [5], the
complex of 47 and 18 kDa peptides is also known to be
adsorbed onto the surface of free merozoites [6,7]. The
P126 protein contains cysteine protease domains [8], sug-
gesting that it may have an essential function in merozoite
release [9] and reinvasion. Monoclonal and polyclonal
antibodies against P126 are able to inhibit parasite
growth in vitro, and a major parasite-inhibitory epitope
has been recently mapped to its 47 kDa N-terminal
extremity (octamer repeats domain – OR domain)
[10,11]. Moreover, immunization of Saimiri  and  Aotus
monkeys with different fractions of P126, including the
Nt47 domain [1,12-15], induced antibodies that pro-
tected monkeys against challenge infection. Immuno-epi-
demiological studies performed in holoendemic
(Uganda) and mesoendemic (Brazil) areas have displayed
a positive association between naturally acquired cyto-
phylic IgG antibody response to the OR domain and an
increased protective immunity in adults [16,17] and chil-
dren [16,18], suggesting that cellular effector mecha-
nisms, such as antibody-dependent cellular inhibition
targeting the P126 protein, might play a primary role in
protection against malaria. However, it was observed that
malaria-infected people with different degrees of expo-
sure, as naïve tourists experiencing their first infection or
chronically exposed individuals from areas exhibiting a
different level of endemicity (Senegal and Brazil), devel-
oped anti-OR antibodies with similar prevalence (77%)
[17]. The lack of response in the remaining 23% of the
patients could be due to a genetic restriction of the
immune response to the OR domain. In fact, in previous
work there were significant associations between anti-OR
response and the presence of HLA-DR4, and the absence
of anti-OR response with the presence of HLA-DR15 [19].
Therefore, genetic restriction alone cannot explain these
findings since not all HLA-DR15 individuals were non-
responders as well as not all HLA-DR4 individuals were
responders. Genetic diversity of P. falciparum antigen
repetitive regions is thought to contribute to immune
invasion and also appear to restrict the effectiveness of
subunit vaccines. In fact, although the P126 structure has
been proven to be remarkably conserved among P. falci-
parum isolates, the P126 gene is a member of a multigene
family [20]. Most polymorphism has been described in
exon II which corresponds to the amino terminal region
(47 kDa peptide) of the protein that encodes two repeat
domains: the octamer repeats (Nt47 = OR domain) and
the serine repeats (SR domain) characterized by a stretch
of serine residues. The P126 polymorphisms basically
comprise the events of deletions/insertions in these two
repetitive domains of the protein, but nucleotide replace-
ments, synonymous or not, were also described [21-24].
The OR region predominately consists of six octamer
units (OR-II), but variation in the sequence and number
of repeat units (5 octamer units – OR-I) may be seen in
different alleles [24]. The occurrence of polymorphism in
the OR domain, which encodes B- and T-epitopes [25]
involved in the induction of the protective immunity,
may provide a mechanism for parasites to evade immune
response induced by either natural exposition to infec-
tions or vaccine. Recently, analyses of P. falciparum iso-
lates (n = 52) from three areas of the Brazilian Amazon
have identified the occurrence of the two P126 OR frag-
ments, the most frequent constituting six octamer repeats
[26]. The study of P126 OR domain polymorphism influ-
ence on the naturally acquired specific antibody responses
in individuals living in malaria-endemic areas may pro-
vide valuable insights for vaccine development against
this high priority disease. In this context, the goal of thisMalaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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study was to extend the knowledge of P126 OR domain
genetic polymorphism in Brazilian P. falciparum isolates
(by PCR-SSCP and sequencing) and evaluate its impact on
the natural OR-antibody responses in malaria-exposed
Brazilian Amazon individuals.
Methods
Study sites
The study was carried out in two villages, Candeias do
Jamari (8°48'35"S; 63°41'44"W) in Rondonia state and
Peixoto de Azevedo (10°13'23"S; 54°58'47"W) in Mato
Grosso state, both located in the south-western part of the
Amazon region. This region became the target of a large
influx of people from other Brazilian regions during the
70s and 80s and malaria is hypoendemic to mesoendemic
and is present throughout the year with seasonal fluctua-
tions. The economic activities in both villages were sub-
sistence farming, but gold-mining have become an
attractive trade to Peixoto de Azevedo village. The popula-
tion of Candeias do Jamari is composed of natives (30%)
and migrants (70%) inhabiting this area for variable times
since the 1970s. The first sample set were collected in
1993 (Candeias do Jamari-1993) and the second sample
set was obtained nine years later, in 2002 (Candeias do
Jamari-2002). The average annual parasite incidence
(API), in Candeias do Jamari, was 549 in 1993 and 173 in
2002. For reference, the Brazilian Ministry of Health con-
siders high risk areas those with API ≥ 50. The population
of Peixoto de Azevedo is consisted mainly of gold miners
and they frequently come from other gold prospecting
places inside the Amazon. The samples were collected in
1995 in Peixoto the Azevedo (PA group) when the API
was 292. Malaria transmission in both villages occurs
throughout the year, with seasonal fluctuations with an
increase of incidence at the beginning and at the end of
dry season when all samples were collected.
Patients and isolates
Written informed consent was obtained from all donors
and venous blood samples were taken from P. falciparum
infected individuals: 96 from Peixoto de Azevedo in 1995,
103 from Candeias do Jamari in 1993 (Candeias do
Jamari-1993 group) and 78 Candeias do Jamari in 2002
(Candeias do Jamari-2002 group). OR fragments poly-
morphism in samples from three cohorts (CJ 1993, CJ
2002 and PA) were used in order to evaluate whether the
OR fragment polymorphism in Brazil was present and
appeared to be temporally stable in the same area (1993
and 2002) or if it was spread throughout different areas
(Candeias do Jamari and Peixoto de Azevedo). All P. falci-
parum malaria patients who were enrolled in this study
complied with the following criteria: 1) they presented
symptoms; 2) they had unique P. falciparum thick blood
smears; 3) they neither used chemoprophylaxis nor took
antimalarial drugs (self-treatment); 4) they were all over
15 years old; 5) no females were pregnant or breast feed-
ing and; 6) blood collection was performed the day of
diagnosis before malaria treatment. The patients sought
health care at Brazilian health services 3.6 ± 1.8 days after
onset of symptoms. After blood sample collection, the
patients were immediately treated according to Brazilian
Ministry of Health standards for malaria therapy with qui-
nine plus doxycycline and primaquine.
Thin and thick blood smears were examined for identifi-
cation of malaria parasite by two expert malaria micro-
scopists from Brazilian Malaria Health Services and from
the Laboratory of Malaria Research (Fiocruz) which is a
reference in malaria diagnosis from Brazilian Ministry of
Health. Thick blood smears from all subjects were stained
with Giemsa, and a total of 200 microscopic fields were
examined under 1000-fold magnification. Thin blood
smears of positive samples were examined for species
identification. Only patients infected with P. falciparum in
the thick and thin blood smears were enrolled in our
study. The P. falciparum parasite density was determined
by counting parasites in a predetermined number of white
blood cells in thick blood films, and the number of blood
parasites per milliliter was calculated [27]. The fresh
blood samples were washed three times with 0.15 M
phosphate-buffered saline and pellet containing packed
red blood cells was mixed with equal volume of cryop-
reservation solution (0.9% NaCl/4.2% sorbitol/20% glyc-
erol) and frozen in liquid nitrogen (N2).
DNA extraction
The isolation of DNA from blood was carried out using
the method previously described [28]. One μL of red
blood cells was lysed by saponin lysis buffer (15%) and
then centrifuged at 7,000 × g for 10 min. The pellets were
mixed with 300 μL of NET buffer (150 mM NaCl, 10 mM
EDTA, and 50 mM TRIS, pH 7.0) containing 0.1% (w/v)
Sarcosyl and 200 μg proteinase K and were kept for 3 h at
42°C. The sample was then extracted once with phenol/
clorophorm/isoamyl alcohol (25/24/1 w/v) and then
once with clorophorm/isoamyl alcohol (24/1 w/v). The
DNA was precipitated with cold ethanol and reconstituted
in 50 μL of TE buffer (10 mM TRIS-HCl and 1 mM EDTA,
pH 8.0).
Amplification of the P126 gene fragment and 
electrophoresis
The repetitive region of the gene encoding the P126 anti-
gen was amplified in a Nested PCR method using the first
set of primers p126A (5'-AAT GAA GTC ATA TAT TTC CTT
G-3') and p126B (5'-CAA TGT TGT TCT TAA TTC GAT A-
3') and the second set of primers p126C (5'-GTG TTA TAT
TTA ACA AAA ATG-3') and p126D (5'-CTT ACA GGA TTG
CTT GGT TCG-3') [29]. One μL of DNA was amplified in
a 50 μL reaction volume containing 10 nmol of eachMalaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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deoxynucleotide triphosphate (dNTP, Promega, Madison,
WI), 100 pmoles of each primer (Invitrogen, USA), 2.5 U
of AmpliTaq® DNA Polymerase (Applied Biosystems, Fos-
ter City, CA) and 5 μL of 10× buffer (2.0 mM MgCl2,
Promega, Madison, WI). Both single and nested PCR reac-
tions were carried out using a GeneAmp® PCR System
9700 (Applied Biosystem, Foster City, CA) for thirty cycles
(1 min. at 94°C, 2 min. at 47°C, 3 min. at 72°C). Ten μL
of PCR reaction were loaded onto a 2.5% agarose gel
(Sigma, Missouri, USA) in 1× TAE buffer (0.04 M TRIS-
acetate, 1 mM EDTA) in the presence of ethidium bro-
mide (0.5 μg/mL).
Single-strand conformational polymorphism (SSCP)
In order to assess sequence microheterogeneity within
fragments defined as the same genotype by PCR, each
amplified fragment was analysed by SSCP. The PCR sam-
ple was previously concentrated with 0,3 M of sodium
acetate pH 5.2, recovered in 20 μL of distilled water and
loaded onto a 2% Nusieve GTG agarose gel (FCM Bio-
product, USA) in 1 × TAE buffer (0.04 M TRIS-acetate, 1
mM EDTA). The amplified fragments were individually
gel-purified using Wizard PCR preps (Promega, Madison,
WI) as recommended by suppliers and resuspended in 40
μL of distilled water. PCR fragments were digested to com-
pletion with RsaI  (Promega, Madison, WI) and then
extracted with phenol-chloroform and precipitated with
ethanol. The samples were denatured prior to analysis by
adding one μL of 0.5 M NaOH/10 mMEDTA and then
electrophoresed for 3 h at 10 V/cm using 0.5 × TBE buffer
(pH8.4). SSCP patterns were visualized by silver staining
as described elsewhere [30].
DNA Sequencing
Uncloned amplified fragments were sequenced using the
di-deoxy chain termination procedure with Taq polymer-
ase and fluorescently labeled (Big Dye Terminator Kit ver-
sion 3.1, Applied Biosystems, Foster City, CA) with the
primers p126C 5' GTG TTA TAT TTA ACA AAA ATG 3' (for-
ward) and p126D 5' CTT ACA GGA TTG CTT GGT TCG-3'
(reverse). Nucleotide sequences were obtained by the
automated method (DNA sequencer model 3100 Genetic
Analyzer; Applied Biosystems, Foster City, CA) and the
sequences assembled by using SeqMan II, included in the
DNASTAR software package (Madison, Wis.). The OR
domain sequences reported for field isolates have been
submitted to EMBL/GenBank Data libraries under acces-
sion number EU360815 and EU360816.
The graphical representations of the predicted antigenic
determinants on the OR domains were generated using
the program DNASTAR software package (Madison, Wis.)
and the antigenic indexes were calculated using the
method described by Jameson & Wolf [31].
Nt47 peptide
The Nt47 synthetic peptide corresponding to the six
octamer repeats (OR-II) of the P126 amino terminal
region [32,33] was prepared using a solid-phase method
[34] as previously described [35]. The amino acid
sequence of the Nt47 is Thr Gly Glu Ser Gln Thr Gly Asn
– Thr Gly Gly Gly Ala Gly Asn – Thr Gly Gly Gly Gln Ala
Gly Asn – Thr Val Gly Asn Gln Ala Gly Ser – Thr Gly Gly
Ser Pro Gln Gly Ser – Thr Gly Ala Ser Gln Pro Gly Ser –
Cys. The OR-II domain was selected instead of OR-I (five
octamer repeats) because in the ELISA competition assay
using human sera from endemic regions that recognize
Nt-t47 react with peptides containing at least four repeats
[17]. In addition, the OR-II domain is predominantly
present in P. falciparum parasite isolates from different
malaria endemic regions [24].
Enzyme-linked immunosorbent assay (ELISA) for Nt47 
(OR-II domain)
The ELISA was performed as previously described [17,19].
Briefly, microtiter 96-well plates (Maxisorp, NUNC, Den-
mark) were coated overnight at 4°C with 2 μg/mL of Nt47
peptide in 0.05 M NaHCO3 pH 9.6. After blocking with
4% bovine serum albumin (BSA)/0.05%Tween 20 in PBS
(1 hr at 37°C) and washing with Milli-Q water – 0.05%
Tween 20, human sera diluted in 1% BSA/0.05% Tween
20/PBS (1:100) were added to the plates. After incubation
(1 hr at 37°C), the plates were washed and appropriate
peroxidase-conjugated anti-human IgG or IgM (Sigma,
Missouri, USA) in 1% BSA/0.05% Tween 20/PBS was
added and incubated for 1 hr at 37°C. In order to detect
specific IgG subclasses, plates were incubated for 2 hr at
37°C with murine MAb labeled with peroxidase specific
for human IgG1 (clone 4E3), IgG2 (clone 31-7-4), IgG3
(clone HP 6050) and IgG4 (clone HP 6025) subclasses
(Southern Biotech, Alabama, USA). Bound antibodies
were detected with the substrate orthophenylediamine
(Merck, Rio de Janeiro, Brazil) and H2O2 in citrate-phos-
phate buffer pH 5.0. Plates were read at 492 nm in a spec-
trophotometer (Spectramax 250, Molecular Devices).
Each sample was tested in duplicate. Sera from 25 control
individuals living in Rio de Janeiro and never exposed to
malaria transmission, were used to establish the normal
range for the assay. The cutoff value was determined as the
mean optical density (OD) 3 standard deviations of the
Rio controls (cutoff values: IgG = 0.135; IgM = 0.168;
IgG1 = 0.138; IgG2 = 0.159; IgG3 = 0.142; IgG4 = 0. 172).
To standardize the OD data obtained in different experi-
ments and to evaluate the specific antibody levels, an OD
index was calculated for each immunoglobulin determi-
nation as the ratio between the absorbance of each tested
samples and the cutoff values. Sample with OD index >
1.0 was considered positive.Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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Statistical analysis
The data were stored in the Fox-plus® (Borland Interna-
tional, Inc. Perrysburg, OH) data bank software. Statistica
(Microsoft, Inc. Redmond, WA) and Epi-Info 6 (Centers
for Disease Control and Prevention, Atlanta, GA) statisti-
cal software programs were used for data analysis. The Stu-
dent's t-test was used to analyse the differences in mean
values, the chi-square test was used to analyse the differ-
ence in prevalence of positive responses and of allelic fre-
quencies, and the Spearman rank coefficient test used to
analyse the correlations between variables.
Results
Characteristics of the studied groups
Throughout the study period, 277 P. falciparum samples
were collected from malaria patients from Candeias do
Jamari-1993 (n = 103), Candeias do Jamari-2002 (n = 78)
and Peixoto de Azevedo (n = 96). The average age was
similar among individuals from Candeias do Jamari-1993
(30 ± 12 years old), Candeias do Jamari-2002 (33 ± 14
years old) and Peixoto de Azevedo (29 ± 10 years old).
The time of residence of individuals in the endemic
regions were 13 ± 10 years in Candeias do Jamari-1993,
21 ± 11 years in Candeias do Jamari-2002 and 4 ± 3 years
in Peixoto de Azevedo, the Candeias do Jamari-1993 and
Candeias do Jamari-2002 groups residing on average
longer in a malaria endemic area than that in Peixoto de
Azevedo (Student's t-test;  P  < 0.0001, for both). As
expected, the Candeias do Jamari-2002 group had a
higher mean time of residence in the malaria endemic
area than the Candeias do Jamari-1993 group (Student's t-
test; P < 0.0001). The mean parasitaemia at the time of
blood collection were 9,642 ± 10,301, 2,150 ± 654 and
9,288 ± 9,058 parasites/μL in the Candeias do Jamari-
1993, Candeias do Jamari-2002 and Peixoto de Azevedo
groups, respectively. The Candeias do Jamari-2002 group
demonstrated a lower parasitaemia than the Candeias do
Jamari-1993 and Peixoto de Azevedo groups (Student's t-
test; P < 0.0001, for both). The great majority of the indi-
viduals claimed to have experienced malaria episodes pre-
viously. Only 5% (n = 9) of the individuals from Candeias
do Jamari-1993 and 2002 and 9% (n = 9) of the individ-
uals from Peixoto de Azevedo denied prior malaria infec-
tion.
Genetic polymorphism of P126
Only two types of OR fragments were identified in the
studied areas by PCR-SSCP analysis, one of 175 bp (OR-I)
and the other of 199 bp (OR-II). The frequencies of OR-I
and OR-II fragments found in P. falciparum wild isolates
were, respectively, 7.4% and 92.6% in Candeias do
Jamari-1993 and 9.8% and 90.2% in Candeias do Jamari-
2002. Predominance of the OR-II fragment was evident in
the P. falciparum samples from Candeias do Jamari both
1993 and 2002. Curiously, a different pattern appeared in
relation to OR fragment frequencies in Peixoto de
Azevedo where OR-I fragment frequency (40.5%) was
slightly lower than the OR-II fragment (59.5%). In Peix-
oto de Azevedo there was a higher frequency for the OR-I
fragment when compared to Candeias do Jamari-1993
and Candeias do Jamari-2002 (Chi-square test; P  <
0.0001, for both Candeias do Jamari groups) while the
frequency of the OR-II fragment was lower (Chi-square
test; P < 0.0001, for both Candeias do Jamari groups).
Table 1 presents the frequency of single and mixed infec-
tions according to the groups. As can be seen, the com-
plexity of the infection in Candeias do Jamari was similar
in the 1993 and 2002 surveys, and there was a P. falci-
parum mixed infection with OR-I and OR-II fragments in
4.9% (Candeias do Jamari-1993) and in 5.1% (Candeias
do Jamari -2003). It is interesting to note that in Peixoto
Table 1: Infection patterns of the Plasmodium falciparum isolates from Candeias do Jamari and Peixoto de Azevedo analysed by Nested 
PCR. 
Complexity
 infection
OR
fragments
(bp)
Candeias do Jamari (CJ) Peixoto de Azevedo
 (PA)
1993 2003
n (%) n (%)
Single infections1
I (175) 3 (3%) 4 (5%) 27 (28%)a, b
II (199) 95 (92%) 70 (90%) 49 (51%)c, d
Mixed infection2
I + II (175/199) 5 (5%) 4 (5%) 20 (21%)e, f
Total 103 (100%) 78 (100%) 96 (100%)
1Isolates with one fragment; 2Isolates with two fragments; bp: base pair; n: number of isolates (the percentage of isolates is given in parentheses); a: 
P < 0.0001, PA > CJ-1993; b: P < 0.0001, PA > CJ-2002; c: P < 0.0001, PA < CJ-1993; d: P < 0.0001, PA < CJ-2002; e: P = 0.001, PA > CJ-1993; f: P = 
0.003, PA > CJ-2002. The chi-square test was used to analyse the difference in allelic frequencies.Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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de Azevedo, there was a higher frequency of mixed infec-
tion (20.8%) than in Candeias do Jamari P. falciparum iso-
lates (Chi-square test; P = 0.001 PA versus CJ-1993; P =
0.0034 PA versus  CJ-2002). No relationship was estab-
lished between infection patterns and age, sex or time of
residence in endemic areas of Candeias do Jamari-1993,
Candeias do Jamari-2002 and Peixoto de Azevedo.
DNA sequencing of the OR domain (Nt47)
Comparing the DNA sequencing of OR-I and OR-II frag-
ments of wild P. falciparum isolates from Candeias do
Jamari-1993, Candeias do Jamari-2002 and Peixoto de
Azevedo, a high conservation among predicted amino
acid sequences of the P126 N-terminal extremity was evi-
dent. As shown in Figure 1, OR-I and OR-II fragments of
Brazilian wild parasite isolates differ from each other by
the insertion of the octamer unit (GQAGNTVG) between
amino acid residues 33 and 34. The OR-I Brazilian frag-
ment corresponded to the Honduras 1-type, differing only
by one non-synonymous amino acid replacement at the
42nd (D→G) position, and the OR-II Brazilian fragment
corresponded to the FCR3-type, differing by the two non-
synonymous amino acid replacement at the 40th (G→V)
and 42nd (G→D) positions. The computer-predicted an
antigenic index of the OR-I and OR-II domains from Bra-
zilian isolates, demonstrating that in spite of the OR-I and
OR-II domains presenting a similar antigenic-index scores
(0.86 and 0.87, respectively), OR-II contains 3 antigenic
sites whereas OR-I contains 2 (Figure 2).
Antibody responses to the OR domain regardless of the 
infection patterns
The Nt47 synthetic peptide, which is based on the six
octamer repeat sequence located at the N-terminal
extremity of P126 (OR-II), was used in ELISA to detect
specific IgM, IgG and IgG subclasses. Most of the individ-
uals were tested for humoral immune responses against
the OR-II domain.
There was a predominance of OR domain antibody
responders, regardless of the class (IgG or IgM), in the
Candeias do Jamari-2002 group (92%) when compared
with those observed in Candeias do Jamari-1993 (78%, P
= 0.01 by chi-square test) or Peixoto de Azevedo (80%, P
= 0.02 by chi-square test) (Total – Table 2). This predom-
inance was not associated with either the time of resi-
dence in a malaria endemic area, sex or age. However, in
the Candeias do Jamari-1993 and Peixoto de Azevedo
groups, the parasitaemia was significantly lower in OR
antibody responders (mean = 7,857 ± 8,688 parasites/μL;
8,356 ± 8,070 parasites/μL, respectively) compared to
non-responders (mean = 16,504 ± 13,257 parasites/μL, P
= 0.04; 14,284 ± 12,081 parasites/μL, P = 0.01, respec-
tively, by Student's t-test). As shown in Table 3, the preva-
lence of OR IgG responders in Candeias do Jamari-1993
(70%) and Candeias do Jamari-2002 (74%) was not sta-
tistically different than that observed in the Peixoto de
Azevedo group (79%). However, the IgG antibody levels
(OD index) were higher in Candeias do Jamari-2002 (8.6
± 8.3) than in the Candeias do Jamari-1993 (4.9 ± 3.0) or
Peixoto de Azevedo (4.5 ± 2.8) groups (Student's t-test; P
< 0.05, for both – Table 3). In relation to anti-OR IgM
antibodies the prevalence and the levels were higher in
Candeias do Jamari-2002 (81% and 4.9 ± 4.8) than that
observed in either Candeias do Jamari-1993 (63% and 3.4
± 2.0) or Peixoto de Azevedo (54% and 2.3 ± 1.5) (Chi-
square test and Student's t-test; P < 0.05, for all analyses –
Table 3). No association was derived with respect to age,
Alignment of the predicted amino acid sequences of P126 OR region from Candeias do Jamari and Peixoto de Azevedo P. falci- parum isolates (GenBank accession number EU360815 and EU360816) Figure 1
Alignment of the predicted amino acid sequences of P126 OR region from Candeias do Jamari and Peixoto de 
Azevedo P. falciparum isolates (GenBank accession number EU360815 and EU360816). The OR fragments OR-I and OR-II 
from Brazil were compared one each other and to FCR3 and Honduras1 OR described sequences reported by Morimatsu and 
others [22] and Liu and others [35]. The motif insertion is underlined, the lake of corresponding residues is indicated by dash, 
different residues are indicated in boldface letters and two (OR-I) or three (OR-II) antigenic determinants are in box.
Honduras 1
...OR-I 23 T G E S Q T G N T G G -- -- ---- - DQAGNTVG DQAGSTGG SPQGSTGA SQPGSSEP65
FCR3
...OR-II 23 TGE SQTGNTGG GQAGNTGG GQAGNTVG DQAGSTGG SPQGSTGA SQPGSSEP73
Brazil
OR-I 23 TGE SQTGNTGG - - - - - - - - G QAGNTVG DQAGSTGG SPQGSTGA SQPGSSEP65
OR-II 23 TGE SQTGNTGG GQAGNT V G D QAGNTVG DQAGSTGG SPQGS TGA SQPGSSEP73Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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sex, parasite densities or time of residence in a malaria
endemic area and the prevalence or levels of OR IgG and
IgM antibody responses in any of three groups studied
(Chi-square test, Student's t-test and Spearman rank coef-
ficient test; P > 0.05, for all).
For the majority of individuals with a detectable IgG-OR
antibody, subclasses of IgG were determined in Candeias
do Jamari-1993 (49 of 53, 92%), Candeias do Jamari-
2002 (58 of 58, 100%) and Peixoto de Azevedo (70 of 71,
98%) groups. As shown in Table 3, the IgG subclass pro-
files were different in the Candeias do Jamari-2002 (IgG3
= 60%; IgG4 = 41%; IgG2 = 36%; IgG1 = 24%) group
compared to those observed in Candeias do Jamari-1993
(IgG3 = 96%; IgG1 = 87%; IgG4 = 47%; IgG2 = 14%) or
with Peixoto de Azevedo (IgG3 = 97%; IgG1 = 64%; IgG4
= 43%; IgG2 = 7%). There was a predominance of IgG1
and IgG3 OR-specific antibodies (cytophilic) over IgG4
Comparison of the predictive regions of the OR domain Figure 2
Comparison of the predictive regions of the OR domain. The two (OR-I) or three (OR-II) antigenic determinants are 
in box.
OR-I Region
OR-II Region
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42
Alpha, Regions - Garnier-Robson A
Beta, Regions - Garnier-Robson B
Turn, Regions - Garnier-Robson T
Coil, Regions - Garnier-Robson C
Antigenic Index - Jameson-Wolf 0
1.7
-1.7
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50
Alpha, Regions - Garnier-Robson A
Beta, Regions - Garnier-Robson B
Turn, Regions - Garnier-Robson T
Coil, Regions - Garnier-Robson C
Antigenic Index - Jameson-Wolf 0
1.7
-1.7Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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and IgG2 (noncytophilic) in the Candeias do Jamari-1993
and Peixoto de Azevedo groups (Chi-square test; P  <
0.001, for all analyses – Table 3), whereas in Candeias do
Jamari-2002 there was a predominance of IgG3 OR-spe-
cific antibodies (Chi-square test; IgG3 > IgG1 and IgG2, P
< 0.01, for both analyses) the prevalence of IgG1 and IgG3
OR-specific antibodies were significantly lower when
compared with Candeias do Jamari-1993 and Peixoto de
Azevedo groups (Chi-square test; P < 0.05, for all analyses
– Table 3). However, in Candeias do Jamari from 1993 to
2003 the antibody levels were similar except for IgG1 that
was significantly lower in 2002 (Student's t-test; P < 0.001
– Table 3). The levels of OR IgG3 antibodies in each group
significantly exceeded those of other subclasses (Student's
t-test; P < 0.001, for all analyses – Table 3). No association
was derived with respect to age, sex, parasite densities or
time of residence in a malaria endemic area and the prev-
alence or levels of OR IgG antibody subclass in any of
three groups studied (Chi-square test, Student's t-test and
Spearman rank coefficient test; P > 0.05, for all).
Antibody responses to the OR domain according to the 
infection patterns
Due to the small number of individuals with single (only
OR-I) or mixed (OR-I and OR-II simultaneously) P. falci-
parum infections in both Candeias do Jamari-1993 and
Candeias do Jamari-2002, the statistical analysis of anti-
body responses to the OR domain according to the infec-
tion patterns was performed only in the Peixoto de
Azevedo. In this group the prevalence and/or the levels of
OR-specific antibodies regardless of class and subclass –
(Table 2 and Table 4) were broadly similar among the
groups infected with either single or mixed P. falciparum
isolates (Chi-square test and Student's t-test; P > 0.05, for
all analyses).
Comparing the prevalence of OR antibody responders in
the three groups of individuals infected with the P. falci-
parum OR-II fragment, the prevalence of OR IgM antibody
responders was higher in Candeias do Jamari-2002 (81%)
than in the Candeias do Jamari-1993 (62%, P = 0.01) or
Table 2: Prevalence of anti-OR antibody responses in Candeias do Jamari and Peixoto de Azevedo groups according 
Infection patterns Candeias do Jamari (CJ) Peixoto de Azevedo (PA)
1993 2002
Single1
OR-I 3/3 3/4 21/25 (84)
OR-II 52/69 (75) 65/70 (93)a, b 36/46 (78)
Mixed2 4/4 4/4 16/20 (80)
TOTAL 59/76 (78) 72/78 (92)c, d 73/91 (80)
to the infection patterns.
1Isolates with one fragment; 2Isolates with two fragments. The data represent the number of responders/number of tested individuals (the 
percentage of responders is given in parentheses). a: P = 0.005, CJ-2002 OR-II > CJ-1993 OR-II; b: P = 0.04, CJ-2002 > PA OR-II; c: P = 0.01, CJ- 
2002 > CJ-1993; d: P = 0.02, CJ- 2002 > PA. The Chi-square test was used to analyse the difference in prevalence of positive responses.
Table 3: Prevalence and levels of antibodies to the OR domain of the P. falciparum P126 protein in Candeias do Jamari and Peixoto de 
Azevedo groups regardless of the infection patterns.
PA (a) CJ-1993 (b) CJ-2002 (c) P values
IgG 71/90 (79%) 53/76 (70%) 58/78 (74%) n.s.
4.5 ± 2.8 4.9 ± 3.0 8.6 ± 8.3 a × c: 0.0006; b × c: 0.002
IgM 49/90 (54%) 43/68 (63%) 63/78 (81%) a × c: 0.0006; b × c: 0.02
2.3 ± 1.5 3.4 ± 2.0 4.9 ± 4.8 a × c: 0.0002; b × c: 0.04
IgG1 45/70 (64%) 43/49 (87%) 14/58 (24%) a × b: 0.007; a × c: < 0.0001; b × c: < 0.0001
2.3 ± 2.0 3.2 ± 2.0 1.9 ± 0.7 b × c: 0.001
IgG2 5/70 (7%) 7/49 (14%) 21/58 (36%) a × c: 0.0001; b × c: 0.01
1.3 ± 0.4 2.8 ± 2.8 1.3 ± 0.4 n.s.
IgG3 68/70 (97%) 47/49 (96%) 35/58 (60%) a × c: < 0.0001; b × c: < 0.0001
8.1 ± 6.4 10.2 ± 9.7 7.9 ± 6.1 n.s.
IgG4 30/70 (43%) 23/49 (47%) 24/58 (41%) n.s.
1.3 ± 0.2 1.6 ± 0.7 2.5 ± 2.2 n.s.
The data represent the number of responders/number of tested individuals (the percentage of responders is given in parentheses) and the antibody 
levels expressed as mean of OD index ± SD. The Student's t-test was used to analyse the differences in mean values, the Chi-square test was used 
to analyse the difference in prevalence of positive responses.Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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Peixoto de Azevedo (59%, P = 0.01) groups (Table 4).
However, the OR IgM antibody levels in the Candeias do
Jamari-2002 group were only slightly higher than in the
Candeias do Jamari-1993 or Peixoto de Azevedo groups
(Student's t-test; P > 0.05 – for all analyses – Table 4).
Comparing the profiles of OR IgG subclasses among the
three groups of individuals infected with the P. falciparum
OR-II fragment (Table 4), there was a predominance of
IgG1 and IgG3 OR-specific antibodies (cytophilic) over
IgG4 and IgG2 (noncytophilic) in the Candeias do
Jamari-1993 and Peixoto de Azevedo groups (Chi-square
test; P < 0.001, for all analyses), whereas in Candeias do
Jamari-2002 there was a predominance of IgG3 OR-spe-
cific antibodies (Chi-square test; IgG3 > IgG1 and IgG2, P
< 0.01, for both analyses). The prevalence of IgG1 and
IgG3 OR-specific antibodies was significantly lower in
Candeias do Jamari-2002 when compared with Candeias
do Jamari-1993 and Peixoto de Azevedo groups (Chi-
square test; P < 0.05, for all analyses). However, in Can-
deias do Jamari from 1993 to 2003 the antibody levels
were similar except for IgG1 that was significantly lower in
2002 (Student's t-test; P < 0.001 – Table 3). The levels of
OR IgG3 antibodies in each group significantly exceeded
those of other subclasses (Student's t-test; P < 0.0008, for
all analyses). No association was derived with respect to
age, sex, parasite densities or time of residence in a
malaria endemic area and the prevalence or levels of OR
IgG antibody subclass in any of three groups studied (Chi-
square test, Student's t-test and Spearman rank coefficient
test; P > 0.05, for all).
Discussion
The aims of this study were to investigate the polymor-
phism of the P126 N-terminal region octamer repeat
domain (OR = Nt47 domain) in P. falciparum isolates
from two important Brazilian malaria endemic areas
(Candeias do Jamari in 1993 and 2002 and Peixoto de
Azevedo in 1995) and assess the impact of OR fragment
polymorphism on specific, naturally acquired antibodies
in the studied populations.
In Africa, Asia and South America, including Brazil
[24,26,36], only one single OR fragment type (OR-I or
OR-II) appeared in P. falciparum malaria infected individ-
uals while in our study, mixed infection (both OR-I and
ORII) was detected for the first time in inhabitants of both
villages with high frequency in Peixoto de Azevedo. Also
noteworthy are the differences in the OR fragment fre-
quencies among P. falciparum isolates from Peixoto de
Azevedo when compared with the isolates from other
endemic areas. In Peixoto de Azevedo the OR-I fragment
frequency (40.5%) was only slightly lower than OR-II
(59.5%). The high mixed infection and single OR-I frag-
ment prevalence in Peixoto de Azevedo in comparison
with isolates from the Candeias do Jamari group as well as
Table 4: Prevalence and levels of antibodies to the OR domain of the P. falciparum P126 protein in Candeias do Jamari and Peixoto de 
Azevedo groups according to the infection patterns.
Infection IgG IgM IgG1 IgG2 IgG3 IgG4
Candeias do Jamari (CJ)
OR-II
CJ-1993 47/69 (68)
4.9 ± 3.0d
39/63 (62)
3.4 ± 2.1
39/44a
(88) 3.2 ± 2.1e
6/44b
(13) 3.1 ± 2.9
42/44c
(95) 10.6 ± 10.0
19/44 (43)
1.6 ± 0.7f
CJ-2002 55/70 (78)
8.4 ± 8.2j
57/70g (81)
4.8 ± 4.8
13/55h (23)
1.9 ± 0.7
19/55i 
(34) 1.3 ± 0.4
35/55 (60)
7.5 ± 6.1
23/55 (42)
2.6 ± 2.2k
Peixoto de Azevedo (PA)
OR-I 19/25 (76)
4.9 ± 2.9
13/25 (52) 
1.7 ± 0.9
13/18l (72) 
2.0 ± 1.8
0/18m
-
18/18n (100)
9.8 ± 6.8
9/18 (50)
1.4 ± 0.2
OR-II 36/46 (78) 
4.3 ± 2.7
27/46 (59)
2.7 ± 1.7
21/36o (58)
2.1 ± 1.7
5/36p (14)
1.3 ± 0.4
34/36q (94)
7.6 ± 6.1
16/36 (44) 
1.3 ± 0.1
Mixed 16/19 (84)
4.5 ± 3.1
9/19 (47) 
2.0 ± 1.4
11/16r(69)
2.9 ± 2.7
0/16s
-
16/16 (100)t
7.5 ± 6.4
5/16 (31)
1.3 ± 0.1
The data represent the number of responders/total of each fragment tested (the percentage of responders is given in parentheses) and the antibody 
levels expressed as mean of OD index ± SD. P < 0.05. a: CJ-1993- IgG1 > IgG2, IgG1 > IgG4; CJ-1993 IgG1 > CJ-2002 IgG1; b: CJ-1993- IgG2 < 
IgG3, IgG2 < IgG4; CJ-1993 IgG2 < CJ-2002 IgG2; c: CJ-1993- IgG3 > IgG4; CJ-1993 IgG3 > CJ-2002 IgG3; d: CJ-1993 IgG < CJ-2002 IgG; e: CJ-
1993 IgG1 > CJ-2002 IgG1; f: CJ-1993 IgG4 < CJ-2002 IgG4; g: CJ-2002 IgM > CJ-1993 IgM, CJ-2002 IgM > PA IgM; h: CJ-2002 IgG1 < IgG3; i: CJ-
2002 IgG2 < IgG3; CJ-2002 IgG2 > PA OR-II IgG2; j: CJ-2002 IgG > PA OR-II IgG; k: CJ-2002 IgG4 > PA OR-II IgG4 l: PA OR-I IgG1 > IgG2; PA 
OR-I IgG1 < IgG3; m: PA OR-I IgG2 < IgG3; PA OR-I IgG2 < IgG4; n: PA OR-I IgG3 > IgG4; o: PA OR-II IgG1 > IgG2; PA OR-II IgG1 < IgG3; p: PA 
OR-II IgG2 < IgG3; PA OR-II IgG2 < IgG4; q: PA OR-II IgG3 > IgG4; CJ-2002 IgG3 < PA OR-II IgG3; r: PA mixed IgG1 > IgG2; s: PA mixed IgG2 > 
IgG3; t: PA mixed IgG3 > IgG4. The Student's t-test was used to analyse the differences in mean values, the Chi-square test was used to analyse the 
difference in prevalence of positive responses.Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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groups from a myriad of other geographical areas, is prob-
ably due to: i) an immunological status of this popula-
tion, since studied individuals from this village, mainly
migrants from malaria-free areas, have been inhabiting a
malaria endemic area for an average of four years, ii) a rel-
atively recent introduction of the variant into this popula-
tion as a consequence of the gold miners' nomadic
behaviour within the Amazon, facilitating new variant
spread throughout the region and iii) the differences in
the biological development of this variant in man and/or
its invertebrate host. Although in a Brazilian endemic area
[26] only single infection had previously been detected,
this study's relatively small sample size may account for
an underestimation of mixed infection scope.
It is well recognized that the complexity of infections may
vary considerably in different epidemiological scenarios
according to age and immune status of the individuals
[37,38]. In the study areas, remarkably no relationship
was established between infection patterns and age, sex or
time of residence in a malaria endemic area.
The sequences herein analysed, further confirm a limited
degree of genetic polymorphism in the P126 OR domain,
namely variation in the number of octamer repeats (OR-I
five or OR-II six) and non-synonymous substitutions in
repeat units [24,26,36]. In addition, there was a remarka-
ble similarity between the P126 OR domain of P. falci-
parum from Candeias do Jamari in 1993 and 2002, a
difference of 9 years, suggesting that this portion of the
P126 gene was both genetically homogeneous and tem-
porally stable, and despite differing from the Candeias do
Jamari groups in terms of frequencies and infection com-
plexity, the Peixoto de Azevedo group shared an identical
degree of polymorphism in the P126 OR domain. These
results are similar to a study in the same endemic areas
with the MSP2 protein [39] that revealed genetic similar-
ity between Brazilian isolates from the same areas. Con-
sidering the limited polymorphism of P126 also reported
in other studies in wild and laboratory isolates from
Africa, Asia and South America [21-24,36], the finding of
similar sequences in isolates from the same endemic area
or different geographical areas may be expected. The high
degree of conservation of diverse alleles moreover sup-
ports the hypothesis of a biologically important role for
P126 in parasite development and/or survival.
Based on the fact that B and T-cell epitopes are located in
the OR domain [25], variation in the number of octamer
repeats and non-synonymous substitutions in repeat
units could result in major changes in the affinity of the
antigen-receptor interactions (B-cell receptor, T-cell recep-
tor and MHC molecules) by altering epitope chemical
properties and structure [40], hence theoretically modu-
lating the host immune response, affording parasite eva-
sion. The computer-predicted antigenic index of the OR-I
and OR-II domains from Brazilian isolates demonstrated
that although the OR-I and OR-II domains present similar
antigenic-index scores (0.86 and 0.87, respectively), OR-II
contains three antigenic sites whereas OR-I contains only
two (Figure 2). Indeed, the prevalence of antibody
responses to the P126 OR domain was very high in all
studied groups regardless of the infection patterns (OR-I,
OR-II or mixed). The high prevalence of antibodies to the
OR domain in all three studied groups illustrates that the
P126 OR domain is highly immunogenic in man, which
is in agreement with data from holoendemic
[16,18,25,41] and mesoendemic areas [17,19,41].
One should be aware that a similar profile of IgG, IgG-iso-
types and IgM antibody responses to the OR domain was
apparent in the Candeias do Jamari -1993 and Peixoto de
Azevedo groups, both exhibiting a predominance of IgG1
and IgG3 OR specific antibodies together with both
cytophilic and complement fixing isotypes, in accordance
with the data recently reported for the Uganda population
[18]. However, in Candeias do Jamari, from 1993 to
2002, there was a distinct pattern of antibody response to
the P126 OR domain. In Candeis do Jamari 1993, IgG1
and IgG3 P126 OR responders were predominant whereas
in 2002 the predominant subclasses were IgG3 and IgG4.
However, in 2002 the frequency of IgM and IgG2
responders increased while IgG1 and IgG3 decreased in
comparison with 1993, although antibody levels were
similar in both groups excluding IgG1 which was signifi-
cantly lower in 2002. Therefore, it was herein demon-
strated that P126 OR domain elicits IgG3 antibody
response polarization in each group regardless of the
infection patterns. The IgG1 and IG3 subclasses are
thought to be involved in antimalarial immunity medi-
ated by monocytes through antibody-dependent cytotoxic
inhibition. In this respect, IgG1 and IgG3 antibodies are
the predominant IgG subclass responses to the OR
domain and are associated with protection in man living
in malaria-endemic areas [16,17]. The marked switch of
anti-OR IgM and IgG isotype patterns present in the Can-
deias do Jamari groups from 1993 to 2002 is probably
related to the decrease of parasite density from 9,642 in
1993 to 2,150 parasites/μL in 2002, the decrease of the
API from 549 in 1993 to 173 in 2002 and increased cumu-
lative exposure time to malaria infection from 13 to 21
years. Moreover, the Peixoto de Azevedo group as well as
Candeias do Jamari-1993 presented high parasite density
(9,288 and 9,642 parasites/μL, respectively), API (292
and 549, respectively), short cumulative exposure time to
malaria infection (4 and 13 years, respectively) and simi-
lar IgG, IgM and IgG isopype patterns of anti-OR antibod-
ies. These findings are in line with previous reports
[42,43] that have shown an increase of both IgG1 and
IgG3 prevalence associated with increase in malaria trans-Malaria Journal 2008, 7:144 http://www.malariajournal.com/content/7/1/144
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mission and parasite load. These data suggest that individ-
ual exposed to malaria infections for a shorter period of
time (Candeias do Jamari -1993 and Peixoto de Azevedo)
develop little acquired immunity, consequently present-
ing high parasitaemia levels which could boost the IgG1
and IgG3 response and prevalence. In contrast, individu-
als exposed to malaria infection for a longer period of
time (Candeias do Jamari -2002), develop some level of
acquired immunity, consequently displaying low parasi-
taemia which may not be able to enhance the antibody
subclass responses. If IgG1 and IgG3, specific to the OR-
domain, participate in the protection, as declared in sev-
eral studies of the immune response to P. falciparum vac-
cine candidates [17,42,44-47], the parasite levels may
modulate the induction of antibody subclass responses
necessary to control parasitaemia through differential
catabolism and/or use of these antibodies.
One should be aware that the prevalence of antibody
responses to the OR domain in the Peixoto de Azevedo
group infected with different patterns of the P. falciparum
P126 OR domain presented a similar profile of IgG, IgG
subclasses and IgM antibody response to the OR domain.
Therefore, infection with P. falciparum containing OR-I
and/or OR-II does not influence the response to the OR-II
domain suggesting cross-reactivity of two epitopes within
the repetitive sequence. Indeed, ELISA competition assay
has already demonstrated that human sera from a popu-
lation exposed to malaria recognize OR domains contain-
ing a minimum of four repeats [17].
Conclusion
In conclusion, there is a display of a limited genetic poly-
morphism of the P126 OR domain in P. falciparum iso-
lates in a Brazilian population. This polymorphism does
not seem to influence the development of a specific
humoral immune response (quality and immunogenic-
ity), which is paramount considering that genetic poly-
morphism, even though limited in regions encoding
immunodominant epitopes, is important for malaria vac-
cine development regarding the potential parasite escape
mechanisms involved with respect to the host immune
system. Thus in addition, it was confirmed that there was
the predominance of cytophilic antibodies against the
P126 OR domain could participate in cellular antibody
cooperation mechanisms, which might play a prime role
in the development of protective immune responses
against P. falciparum malaria infection [17,42,47]. Finally,
the P126 OR domain could be included as a component
of a multi-valent malaria vaccine.
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